Deglutition Disorders
Conditions
Keywords
Deglutition Disorders, Dysphagia, cricopharyngeus muscle, Circular sphincter, Esophagus, Botulinum toxin
Brief summary
R-CPD syndrome (Retrograde Cricopharyngeal Dysfunction syndrome) is an inability to burp. It is a syndrome whose diagnosis is clinical, and for which there is effective treatment. Recently treated in the United States (first publication in 2019), this syndrome affects many patients in France and is currently unknown. This study concerns a series of patients treated at the University Hospitals of Strasbourg for a syndrome of retrograde dysfunction of the cricopharyngeus muscle having been treated by injection of botulinum toxin into the cricopharyngeus muscle.
Interventions
None listed
Sponsors
University Hospital, Strasbourg, France
Study design
Observational model
CASE_CONTROL
Time perspective
RETROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Inclusion criteria
* Major subject (≥18 years old) * Subject treated by injection of botulinum toxin into the cricopharyngeal muscle after having had a diagnosis of R-CPD in consultation between January 1, 2022 and December 31, 2022 * Subject not opposing the reuse of their data for the purposes of this research.
Exclusion criteria
* Subject having expressed opposition to participating in the study, * Subject under judicial protection * Subject under guardianship or curatorship
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Retrospective description of the characteristics of a series of patients treated for dysphagia syndrome | Through study completion, an average of 2 months | Retrospective study of medical files of patients treated in HUS between January 1, 2022 and December 31, 2022 |
Countries
France
Contacts
Primary ContactChristian DEBRY, MD, PhD
Outcome results
None listed